[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease 5%, driven by lower...
Source: Roche Investor Update - July 27, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Basel, 27 July 2023Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease ...
Source: Roche Media News - July 27, 2023 Category: Pharmaceuticals Source Type: news
A Shot in the Arm Can Prevent Cervical Cancer
Afshan Bhurgri, a cancer survivor, advises women to listen to their bodies and be aware of the symptoms of cervical cancer. Credit: Zofeen Ebrahim/IPSBy Zofeen EbrahimKARACHI, Jul 26 2023 (IPS) “Listen to your body, and if there is anything strange happening, do not ignore it,” is the advice of 57-year-old Afshan Bhurgri, a cancer survivor.
Eight years ago, she was diagnosed with cervical cancer at a time when she was “in a good place” in life. Her kids were grown up, and she had more time to herself. A fitness freak, the schoolteacher’s daily routine included going to the gym daily. “I joined a creative writin...
Source: IPS Inter Press Service - Health - July 26, 2023 Category: International Medicine & Public Health Authors: Zofeen Ebrahim Tags: Asia-Pacific Development & Aid Editors' Choice Featured Gender Headlines Health Human Rights Humanitarian Emergencies Sustainable Development Goals TerraViva United Nations Women's Health Education Cannot Wait (ECW) IPS UN Bureau Source Type: news
More CIN2+ Detection Seen With HPV Catch-Up Screening in Women Aged ≥65
TUESDAY, July 11, 2023 -- For women aged 65 to 69 years, catch-up human papillomavirus (HPV) screening is associated with higher cervical intraepithelial neoplasia (CIN) grade 2 or worse (CIN2+) detection, according to a study published online July... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 11, 2023 Category: Pharmaceuticals Source Type: news
Liquid Biopsy May Help May Identify HPV-Associated Oropharyngeal Cancer
(MedPage Today) -- MONTREAL – Analysis of circulating human papillomavirus (HPV) tumor DNA and tumor DNA fragment (tumor tissue–modified viral ([TTMV])-HPV DNA using a commercially available blood test – a so-called liquid biopsy... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - July 10, 2023 Category: Surgery Source Type: news
Liquid Biopsy May Help Identify HPV-Associated Oropharyngeal Cancer
(MedPage Today) -- MONTREAL – Analysis of circulating human papillomavirus (HPV) tumor DNA and tumor DNA fragment (tumor tissue–modified viral ([TTMV])-HPV DNA using a commercially available blood test – a so-called liquid biopsy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 10, 2023 Category: Hematology Source Type: news
Sample-to-Answer, Point-of-Care HPV DNA Test Feasible
TUESDAY, June 27, 2023 -- A sample-to-answer, point-of-care human papillomavirus (HPV) DNA test is feasible and can be performed by minimally trained personnel, according to a study published online June 21 in Science Translational Medicine.
Kathryn... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Media News - June 13, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Investor Update - June 13, 2023 Category: Pharmaceuticals Source Type: news
Harald zur Hausen, 87, Nobelist Who Found Cause of Cervical Cancer, Dies
When he proposed that the human papillomavirus caused cervical cancer, he was ridiculed. He persevered, and today a vaccine exists. (Source: NYT Health)
Source: NYT Health - June 9, 2023 Category: Consumer Health News Authors: Emily Anthes Tags: zur Hausen, Harald Deaths (Obituaries) Sexually Transmitted Diseases Cervical Cancer Human Papillomavirus (HPV) Vaccination and Immunization Nobel Prizes Research Source Type: news
Put Your Shoes Back On. Here ’ s the Problem With Going Barefoot
Apologies to the dudes who packed away their Allbirds and Crocs in order to parade around town with nothing but sweet air between their feet and the ground. “Barefoot boy summer” has been canceled.
That’s according to podiatrists alarmed at recent reports that people (men in particular) are losing their shoes and hitting the streets—heading to coffee shops, hiking trails, airports, and anywhere else their hearts and soles might lead them. Social-media users on platforms like TikTok are sharing videos of themselves (and others) barefoot in the wild. (“Be that primal, hard-to-kill man you know y...
Source: TIME: Health - June 2, 2023 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate TIME 2030 Wellbeing Source Type: news
Harald zur Hausen, who found virus link to cervical cancer, dies at 87
The research led by Dr. zur Hausen into the human papillomavirus, or HPV, turned a theory that was once on the fringes of scientific acceptance into new fields of ontological study and potentially spared tens of thousands of people from getting cancer. Dr. zur Hausen faced a wall of skepticism at…#zurhausen #hpv #nobelprize #waynelancaster #georgetownuniversity #globeandmail #cdc #haraldzurhausen #gelsenkirchen #westerngermany (Source: Reuters: Health)
Source: Reuters: Health - May 31, 2023 Category: Consumer Health News Source Type: news
Military members half as likely as civilians to receive HPV vaccine
Active-duty military and veterans are twice as likely as civilians to develop cancers associated with human papillomavirus, or HPV. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 28, 2023 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
Vaginal HPV Detected in About 40 Percent of Pregnant Women
FRIDAY, May 26, 2023 -- Vaginal human papillomavirus (HPV) is detected in about 40 percent of pregnant women, but perinatal transmission occurs infrequently, according to a study published online May 22 in JAMA Pediatrics.
Pranamika Khayargoli,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 26, 2023 Category: Pharmaceuticals Source Type: news
No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
(MedPage Today) -- BALTIMORE -- People with access to routine healthcare were more likely to have received human papillomavirus (HPV) vaccination compared with those who did not have this access, a retrospective analysis of National Health and... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 25, 2023 Category: American Health Source Type: news
